Cyclosporine: all 397 studies that test it

Page 2 of 4. Open to participants first (32), then studies with results posted, then the rest; newest registration first within each.

• Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's LymphomaTerminatedNCT00481832Phase 2Results posted
• Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi AnemiaCompletedNCT00453388Phase 2Results posted
• Efficacy and Safety of Cyclosporine A Microemulsion in Maintenance Patients With Chronic Plaque PsoriasisCompletedNCT00438360Phase 3Results posted
• Efficacy and Safety of Everolimus in Combination With Cyclosporine Microemulsion Versus Everolimus in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS), in Adult Renal Transplant Patients in Maintenance.CompletedNCT00425308Phase 3Results posted
• Evaluation of the Therapeutic Benefit of an Initial Intensified Dosing Regimen of Mycophenolate Sodium Versus a Standard Regimen in Renal Transplant PatientsCompletedNCT00419926Phase 4Results posted
• Methods to Enhance the Safety and Effectiveness of Stem Cell TransplantsCompletedNCT00378534Phase 2Results posted
• Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte LeukemiaTerminatedNCT00363779Phase 2Results posted
• Hematopoietic Stem Cell Transplantation in the Treatment of Infant LeukemiaCompletedNCT00357565Phase 2Results posted
• Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow TransplantCompletedNCT00343785Phase 2Results posted
• A Study to Evaluate the Efficiency of Intravenously Administered Cyclosporine in de Novo Liver Transplant RecipientsCompletedNCT00332462Phase 4Results posted
• Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous LeukemiaCompletedNCT00322101Phase 3Results posted
• Allogeneic Bone Marrow Transplantation Using Less Intensive TherapyTerminatedNCT00303719Phase 2Results posted
• Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)CompletedNCT00296296Phase 4Results posted
• Three Immunosuppressive Treatment Regimens for Severe Aplastic AnemiaCompletedNCT00260689Phase 2Results posted
• Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or TacrolimusTerminatedNCT00260208Phase 4Results posted
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic CancerTerminatedNCT00255684Not applicableResults posted
• Alemtuzumab to Treat Severe Aplastic AnemiaCompletedNCT00195624Phase 2Results posted
• Allogeneic Transplantation From Related Haploidentical DonorsCompletedNCT00185692Phase 2Results posted
• Stem Cell Transplant for Immunologic or Histiocytic DisordersCompletedNCT00176865Phase 2Results posted
• Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C InfectionCompletedNCT00163657Phase 4Results posted
• Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant PatientsCompletedNCT00154284Phase 3Results posted
• Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant RecipientsCompletedNCT00149994Phase 4Results posted
• Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative SteroidsCompletedNCT00149890Phase 3Results posted
• Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)CompletedNCT00135811Phase 3Results posted
• Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic SyndromeTerminatedNCT00119366Phase 2Results posted
• Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver TransplantCompletedNCT00118742Phase 4Results posted
• Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00118352Phase 2Results posted
• Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerCompletedNCT00112593Not applicableResults posted
• Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Transplant RecipientsTerminatedNCT00086346Phase 3Results posted
• Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell LymphomaTerminatedNCT00070291Phase 2Results posted
• Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic AnemiaCompletedNCT00065260Phase 2Results posted
• Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's LymphomaTerminatedNCT00057954Phase 2Results posted
• Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple MyelomaCompletedNCT00054353Phase 1/2Results posted
• S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid LeukemiaTerminatedNCT00053014Phase 2Results posted
• Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System CancersCompletedNCT00051311Phase 2Results posted
• Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in RemissionCompletedNCT00045435Phase 2Results posted
• Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic SyndromesCompletedNCT00045305Phase 2Results posted
• Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric SarcomasCompletedNCT00043979Phase 2Results posted
• Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted KidneyCompletedNCT00035555Phase 2Results posted
• Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple MyelomaCompletedNCT00006184Phase 2Results posted
• Antithymocyte Globulin and Cyclosporine to Treat MyelodysplasiaCompletedNCT00005937Phase 2Results posted
• Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory LymphomaCompletedNCT00005803Phase 1/2Results posted
• Specialized Blood Cell Transplants for Cancers of the Blood and Bone MarrowCompletedNCT00003838Phase 2Results posted
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003270Phase 2Results posted
• Stem Cell Transplantation for Metastatic Solid TumorsTerminatedNCT00001880Phase 2Results posted
• CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAAWithdrawnNCT07523009Phase 2
• Photobiomodulation in Combination With Topical Cyclosporine A or TacrolimusCompletedNCT07239128Early Phase 1
• Drug-Drug Interaction of Rifampicin and Cyclosporine on Methotrexate Pharmacokinetics in Healthy SubjectsActive, not recruitingNCT07196449Phase 1
• Intralesional Cyclosporine for Alopecia AreataActive, not recruitingNCT07029204Early Phase 1
• A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory TreatmentCompletedNCT07025811Phase 4
• Once-daily Fluorometholone vs Twice-daily Cyclosporine in Dry Eye DiseaseCompletedNCT06876116Phase 4
• A Study to Learn if Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-07328948 in Healthy AdultsCompletedNCT06837259Phase 1
• A Study Investigating the Effect of Different Approved Medications on How the Body Processes the Study Compound RO7795081CompletedNCT06809608Phase 1
• A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults.CompletedNCT06541678Phase 1
• The COAT Trial: Cequa's Onset of Action TrialCompletedNCT06482177Phase 4
• Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)WithdrawnNCT06246786Early Phase 1
• Improving Drop Instillation Comfort of a Cyclosporine A SolutionCompletedNCT05957211Not applicable
• Topical Cyclosporin A 0.05% Eye Drops for Management of Symptomatic Acquired Punctal Stenosis. A Prospective, Controlled Clinical Study.CompletedNCT05771012Not applicable
• Clinical Outcomes of Cyclosporine Eye Drops in Management of Herpetic KeratitisCompletedNCT05720715Phase 4
• Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment ResponseStatus unknownNCT05692843Phase 4
• Effect of Cyclosporine and Remote Ischemic Preconditioning in Reperfusion Ischemia Injury on Tetralogy Fallot Patients With Correction SurgeryCompletedNCT05691764Not applicable
• Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis TrialCompletedNCT05353101Phase 1
• Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD TreatmentCompletedNCT05294666Phase 4
• Drug-Drug Interaction (DDI) Study of ALXN2050 in Healthy Adult ParticipantsCompletedNCT05202145Phase 1
• A Feasibility Study to Evaluate the Tolerability of Oph1 Compared to Restasis in Healthy VolunteersCompletedNCT05184517Early Phase 1
• A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on RilematovirCompletedNCT05155007Phase 1
• Microvascular and Inflammatory Responses of 0.05 Cyclosporine Eye Drop (II) in Treatment of Dry EyeStatus unknownNCT05131152Not applicable
• A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy AdultsCompletedNCT05109390Phase 1
• Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University HospitalCompletedNCT04979884Phase 3
• Comparison of Safety and Efficacy of de Novo EverolimusCompletedNCT04906304Not applicable
• NMF-CsA-Dupi TrialStatus unknownNCT04878770Not applicable
• CEQUA for Sjogren's Syndrome Dry EyeCompletedNCT04835623Phase 4
• Cyclosporine on Day Zero as Prophylaxis for Cytokine Release SyndromeStatus unknownNCT04781803Phase 2
• A Clinical Trial to Evaluate the Clinical Efficacy of Cyclosporine 0.1% (Ikervis®) for Moderate to Severe Dry Eye Patients. (IKE-03-SWITCHING)Status unknownNCT04775303Phase 4
• Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMNTerminatedNCT04743739Phase 3
• Topical Cyclosporine A for the Treatment of Dry Eye: A Randomized Clinical StudyCompletedNCT04714099Phase 3
• Effect of Ciclosporin Eyedrops on Sjögren SyndromeCompletedNCT04597762Not applicable
• A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological MalignanciesActive, not recruitingNCT04547049Phase 3
• Drug-Drug Interaction Study of Intravenous Administration of SyB V-1901 and Cyclosporine in Japanese Healthy SubjectsCompletedNCT04542252Phase 1
• Cyclosporine A Plus Low-steroid Treatment in COVID-19 PneumoniaStatus unknownNCT04540926Phase 1/2
• Tear Film Markers in Dry Eye SyndromeWithdrawnNCT04515329Phase 4
• I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill PatientsActive, not recruitingNCT04488081Phase 2
• Topical Steroids and Cyclosporin-A for COVID-19 KeratoconjunctivitisStatus unknownNCT04451239Not applicable
• The Effect of Cyclosporin Before Cataract SurgeryCompletedNCT04426240Phase 4
• Multitarget Therapy for Idiopathic Membranous NephropathyCompletedNCT04424862Phase 4
• Cyclosporine in Patients With Moderate COVID-19CompletedNCT04412785Phase 1
• Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19CompletedNCT04392531Phase 4
• Treatment of Corneal Infiltrates Secondary to Epidemic KeratoconjunctivitisCompletedNCT04376970Phase 4
• Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard TherapyStatus unknownNCT04376528Phase 4
• Effect of Cequa Treatment on Accuracy of Pre-operative Biometry & Higher Order Aberrations in Dry Eye Patients Undergoing Cataract SurgeryCompletedNCT04342988Phase 4
• Clinical Efficacy of Two Topical Dry Eye Drops for Central Corneal Stain Clearing Over 90 DaysStatus unknownNCT04172961Phase 4
• Drug Interaction Study of the Effect on Cyclosporine on Ozanimod and Major Active MetabolitesCompletedNCT04149678Phase 1
• Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)TerminatedNCT04039347Phase 3
• Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell TransplantationActive, not recruitingNCT04018937Phase 2
• Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical StudyCompletedNCT04009525Phase 4
• A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative ColitisTerminatedNCT03844932Phase 2
• A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy AdultsCompletedNCT03768609Phase 1
• Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult SubjectsCompletedNCT03750383Phase 1
• Investigation of Flare and Remission in Subjects With Atopic DermatitisWithdrawnNCT03710044Phase 4
• The Comparison of 50% AS Versus PFAT+ 0.05 % COE in Severe Dry Eye SyndromeCompletedNCT03666884Phase 4

← Cyclosporine overview